Abstract
Background
There is controversy over whether IgA nephropathy (IgAN) and Henoch–Schönlein purpura nephritis (HSPN) are the same diseases. This study focuses on the clinicopathological comparison between HSPN and IgAN in children.
Methods
Children with IgAN and HSPN who had a diagnostic renal biopsy were enrolled. This study collected the clinical data of patients at biopsy, re-evaluated the pathological lesions of patients according to the Oxford Classification (MEST-C), and made a retrospective comparison between IgAN and HSPN on different stratifications of the course (Tc) and proteinuria.
Results
A total of 142 children with IgAN and 57 children with HSPN were enrolled. Various stratification showed the same result, which suggested that IgAN showed more mesangial proliferation (M). HSPN showed more segmental glomerulosclerosis in the Tc > 12 m group than IgAN (S 60.0% vs. 9.10%, P = 0.008). In the non-nephrotic-range and nephrotic-range proteinuria group, there were no significant differences in MEST-C scores between IgAN and HSPN.
Conclusion
M is more common in IgAN. HSPN had more S than IgAN over the course of more than 12 months. These results indicate the differences in the pathogenesis in IgAN and HSPN. We propose early biopsy and active treatment of HSPN within 12 months to delay the development of chronic lesions.
Similar content being viewed by others
References
Rai A, Nast C, Adler S. Henoch–Schonlein purpura nephritis. J Am Soc Nephrol. 1999;10(12):2637–44.
Davin JC, Coppo R. Henoch–Schonlein purpura nephritis in children. Nat Rev Nephrol. 2014;10(10):563–73. https://doi.org/10.1038/nrneph.2014.126.
Meadow SR, Scott DG. Berger disease: Henoch–Schonlein syndrome without the rash. J Pediatr. 1985;106(1):27–322.
Davin JC, Ten Berge IJ, Weening JJ. What is the difference between IgA nephropathy and Henoch–Schonlein purpura nephritis? Kidney Int. 2001;59(3):823–34. https://doi.org/10.1046/j.1523-1755.2001.059003823.x.
Heineke MH, Ballering AV, Jamin A, Ben Mkaddem S, Monteiro RC, Van Egmond M. New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch–Schonlein purpura). Autoimmun Rev. 2017;16(12):1246–53. https://doi.org/10.1016/j.autrev.2017.10.009.
Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, et al. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney Int. 2018;93(3):700–5. https://doi.org/10.1016/j.kint.2017.10.019.
Kiryluk K, Novak J, Gharavi AG. Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies. Annu Rev Med. 2013;64:339–56. https://doi.org/10.1146/annurev-med-041811-142014.
Calvo-Rio V, Loricera J, Martin L, Ortiz-Sanjuan F, Alvarez L, Gonzalez-Vela MC, et al. Henoch–Schonlein purpura nephritis and IgA nephropathy: a comparative clinical study. Clin Exp Rheumatol. 2013;31(1 Suppl 75):S45–51.
Mao S, Xuan X, Sha Y, Zhao S, Zhu C, Zhang A, et al. Clinico-pathological association of Henoch-Schoenlein purpura nephritis and IgA nephropathy in children. Int J Clin Exp Pathol. 2015;8(3):2334–422.
Komatsu H, Fujimoto S, Yoshikawa N, Kitamura H, Sugiyama H, Yokoyama H. Clinical manifestations of Henoch–Schonlein purpura nephritis and IgA nephropathy: comparative analysis of data from the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol. 2016;20(4):552–60. https://doi.org/10.1007/s10157-015-1177-0.
Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, et al. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int. 2017;91(5):1014–21. https://doi.org/10.1016/j.kint.2017.02.003.
Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, et al. Prognosis of Henoch–Schonlein nephritis in children. Br Med J. 1977;2(6078):11–4. https://doi.org/10.1136/bmj.2.6078.11.
Wyatt RJ, Julian BA, Bhathena DB, Mitchell BL, Holland NH, Malluche HH. Iga nephropathy: presentation, clinical course, and prognosis in children and adults. Am J Kidney Dis. 1984;4(2):192–200.
Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR/PRINTO/PRES criteria for Henoch–Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010;69(5):798–806. https://doi.org/10.1136/ard.2009.116657.
Schwartz GJ, Work DF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol. 2009;4(11):1832–43. https://doi.org/10.2215/cjn.01640309.
Sanders JT, Wyatt RJ. IgA nephropathy and Henoch–Schonlein purpura nephritis. Curr Opin Pediatr. 2008;20(2):163–70. https://doi.org/10.1097/MOP.0b013e3282f4308b.
Kiryluk K, Moldoveanu Z, Sanders JT, Eison TM, Suzuki H, Julian BA, et al. Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch–Schonlein purpura nephritis. Kidney Int. 2011;80(1):79–877. https://doi.org/10.1038/ki.2011.16.
Nasri H. Oxford classification of IgA nephropathy is applicable to predict long-term outcomes of Henoch–Schonlein purpura nephritis. Iran J Allergy Asthma Immunol. 2014;13(6):456–8.
Cakici EK, Gur G, Yazilitas F, Eroglu FK, Gungor T, Arda N, et al. A retrospective analysis of children with Henoch–Schonlein purpura and re-evaluation of renal pathologies using Oxford classification. Clin Exp Nephrol. 2019;23(7):939–47. https://doi.org/10.1007/s10157-019-01726-5.
Inagaki K, Kaihan AB, Hachiya A, Ozeki T, Ando M, Kato S, et al. Clinical impact of endocapillary proliferation according to the Oxford classification among adults with Henoch–Schonlein purpura nephritis: a multicenter retrospective cohort study. BMC Nephrol. 2018;19(1):208. https://doi.org/10.1186/s12882-018-1009-z.
Huang X, Ma L, Ren P, Wang H, Chen L, Han H, et al. Updated Oxford classification and the international study of kidney disease in children classification: application in predicting outcome of Henoch–Schonlein purpura nephritis. Diagn Pathol. 2019;14(1):40. https://doi.org/10.1186/s13000-019-0818-0.
Xu K, Zhang L, Ding J, Wang S, Su B, Xiao H, et al. Value of the Oxford classification of IgA nephropathy in children with Henoch–Schonlein purpura nephritis. J Nephrol. 2018;31(2):279–86. https://doi.org/10.1007/s40620-017-0457-z.
Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB, et al. The pathophysiology of IgA nephropathy. J Am Soc Nephrol. 2011;22(10):1795–803. https://doi.org/10.1681/asn.2011050464.
Le W, Zeng CH, Liu Z, Liu D, Yang Q, Lin RX, et al. Validation of the Oxford classification of IgA nephropathy for pediatric patients from China. BMC Nephrol. 2012;13:158. https://doi.org/10.1186/1471-2369-13-158.
Tanaka H, Suzuki K, Nakahata T, Ito E, Waga S. Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis. Pediatr Nephrol. 2003;18(4):347–50. https://doi.org/10.1007/s00467-003-1094-4.
Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N. Multiple combined therapy for severe Henoch–Schonlein nephritis in children. Pediatr Nephrol. 1998;12(3):244–8.
Shrestha S, Sumingan N, Tan J, Alhous H, McWilliam L, Ballardie F. Henoch Schonlein purpura with nephritis in adults: adverse prognostic indicators in a UK population. QJM. 2006;99(4):253–65. https://doi.org/10.1093/qjmed/hcl034.
Foster BJ, Bernard C, Drummond KN, Sharma AK. Effective therapy for severe Henoch–Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr. 2000;136(3):370–5. https://doi.org/10.1067/mpd.2000.103448.
Shin JI, Park JM, Kim JH, Lee JS, Jeong HJ. Factors affecting histological regression of crescentic Henoch–Schonlein nephritis in children. Pediatr Nephrol. 2006;21(1):54–9. https://doi.org/10.1007/s00467-005-2068-5.
Hennies I, Gimpel C, Gellermann J, Moller K, Mayer B, Dittrich K, et al. Presentation of pediatric Henoch–Schonlein purpura nephritis changes with age and renal histology depends on biopsy timing. Pediatr Nephrol. 2018;33(2):277–86. https://doi.org/10.1007/s00467-017-3794-1.
Acknowledgements
We thank all our colleagues at the Department of Nephrology, Beijing Children's Hospital, China for providing the pediatric patient case information, Dr. Nan Zhang and Dr. Xingfeng Yao of the Department of Pathology, Beijing Children's Hospital, China for advice regarding renal pathology, and Dr. Lin Hua of the School of Biomedical Engineering, Capital Medical University, China for providing help with the statistical analysis.
Funding
This work was supported by the Capital Health Research and Development of Special Grant (No. 2016-2-2094), the Research on the Application of Capital Clinical Characteristics Program of Beijing Municipal Science and Technology Commission (No. Z161100000516106) and the Project of Beijing Science and Technology Commission (No. D181100000118006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that no conflicts of interest exist.
Ethical approval
The study was approved by the ethics committee of Beijing Children’s Hospital, China. The Ethics Committee specifically stated that informed consent was not required because this study was retrospective and the data analyzed anonymously.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Li, X., Tang, M., Yao, X. et al. A clinicopathological comparison between IgA nephropathy and Henoch–Schönlein purpura nephritis in children: use of the Oxford classification. Clin Exp Nephrol 23, 1382–1390 (2019). https://doi.org/10.1007/s10157-019-01777-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-019-01777-8